<b>Discussion:</b> To summarize, our research showed that elevated IL4I1 levels are indicative of an inflamed TME, the basal subtype, and a more favorable response to various treatment methods, especially immune checkpoint blockade therapy in BLCA. This evidence concerns the gene IL4I1 and bladder transitional cell carcinoma.